DOI QR코드

DOI QR Code

Identifying literature-based significant genes and discovering novel drug indications on PPI network

  • Park, Minseok (Dept. of Computer Engineering, Gachon University) ;
  • Jang, Giup (Dept. of Computer Engineering, Gachon University) ;
  • Lee, Taekeon (Dept. of Computer Engineering, Gachon University) ;
  • Yoon, Youngmi (Dept. of Computer Engineering, Gachon University)
  • Received : 2017.01.26
  • Accepted : 2017.02.24
  • Published : 2017.03.31

Abstract

New drug development is time-consuming and costly. Hence, it is necessary to repurpose old drugs for finding new indication. We suggest the way that repurposing old drug using massive literature data and biological network. We supposed a disease-drug relationship can be available if signal pathways of the relationship include significant genes identified in literature data. This research is composed of three steps-identifying significant gene using co-occurrence in literature; analyzing the shortest path on biological network; and scoring a relationship with comparison between the significant genes and the shortest paths. Based on literatures, we identify significant genes based on the co-occurrence frequency between a gene and disease. With the network that include weight as possibility of interaction between genes, we use shortest paths on the network as signal pathways. We perform comparing genes that identified as significant gene and included on signal pathways, calculating the scores and then identifying the candidate drugs. With this processes, we show the drugs having new possibility of drug repurposing and the use of our method as the new method of drug repurposing.

Keywords

References

  1. Oprea, T. I., and J. Mestres. "Drug repurposing: far beyond new targets for old drugs." The AAPPS journal Vol.14, No. 4, pp.759-763, Jul. 2012 https://doi.org/10.1208/s12248-012-9390-1
  2. Liu, Zhichao, et al. "In silico drug repositioning-what we need to know" Drug discovery today, Vol.18, No. 3, pp. 110-115, Feb. 2013. https://doi.org/10.1016/j.drudis.2012.08.005
  3. Andronis, Christos, et al. "Literature mining, ontologies and information visualization for drug repurposing" Briefings in bioinformatics, Vol.12, No. 4, pp. 357-368, Jul. 2011. https://doi.org/10.1093/bib/bbr005
  4. Jang et al. "Novel Drug Similarity Measuring Method based on Text Mining for Predicting Similar Drugs." Journal of KIIT, Vol.4, No. 7, pp. 127-137, Jul. 2016.
  5. Wu, Zikai, Yong Wang, and Luonan Chen. "Network-based drug repositioning" Molecular BioSystems, Vol.9, No. 6, pp. 1268-1281, Sep. 2013. https://doi.org/10.1039/c3mb25382a
  6. Cheng, Feixiong, et al. "Prediction of drug-target interactions and drug repositioning via network-based inference." PLoS Comput Biol Vol.8, No. 5, pp. ppe1002503, May, 2012. https://doi.org/10.1371/journal.pcbi.1002503
  7. Canese, Kathi, and Sarah Weis. "PubMed: The bibliographic database" The NCBI Handbook. 2013.
  8. Law, Vivian, et al. "DrugBank 4.0: shedding new light on drug metabolism" Nucleic acids research, Vol. 42, No. D1, pp. D1091-D1097, Jan. 2014. https://doi.org/10.1093/nar/gkt1068
  9. Whirl-Carrillo, Michelle "Pharmacogenomics Knowledge for Personalized Medicine" Clinical Pharmacology & Therapeutics, Vol.92, No. 4, pp. 414-417, Oct. 2012. https://doi.org/10.1038/clpt.2012.96
  10. Maglott, Donna, et al. "Entrez Gene: gene-centered information at NCBI" Nucleic acids Research, Vol.39, suppl 1, pp. D52-D57, Jan. 2011. https://doi.org/10.1093/nar/gkq1237
  11. Kibbe, Warren A., et al. "Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data" Nucleic acids research, Vol.43, No. D1, pp. gku1011, Oct. 2014.
  12. Davis, Allan Peter, et al. "The Comparative Toxicogenomics Database's 10th year anniversary: update 2015" Nucleic acids research, Vol.43, No. D1, pp. D914-D920, Jan. 2015. https://doi.org/10.1093/nar/gku935
  13. Lee, Insuk, et al. "Prioritizing candidate disease genes by network-based boosting of genome-wide association data" Genome Research, Vol.21, No. 7, pp. 1109-1121, Jul. 2011. https://doi.org/10.1101/gr.118992.110
  14. Yang, Hong, et al. "Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information" Nucleic acids research, Vol.44, No. D1, pp. D1069-D1074, Jan. 2016. https://doi.org/10.1093/nar/gkv1230
  15. Zarin, Deborah A., et al. "The ClinicalTrials.gov results database-update and key issues" New England Journal of Medicine, Vol.364, No. 9, pp. 852-860, Mar. 2011. https://doi.org/10.1056/NEJMsa1012065
  16. Pinero, Janet, et al. "DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants." Nucleic Acids Research, pp. gkw943, 2016.
  17. Kanehisa, Minoru, et al. "KEGG: new perspectives on genomes, pathways, diseases and drugs." Nucleic Acids Research, Vol.45, No. D1, pp. D353-D361, Jan. 2017. https://doi.org/10.1093/nar/gkw1092
  18. Genetics Home Reference, https://ghr.nlm.nih.gov/resources
  19. Kim et al "Inferring Disease-related Genes using Title and Body in Biomedical Text" KIISE Transactions on Computing Practices, Vol. 23, No. 1, pp. 28-36, Jan. 2017. https://doi.org/10.5626/KTCP.2017.23.1.28
  20. Butcher, J. C. "Random sampling from the normal distribution" The Computer Journal, Vol.3, No. 4, pp. 251-253, Jan. 1961. https://doi.org/10.1093/comjnl/3.4.251